Search Results

Search Results for

GI008

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)

Continue Reading »
NSABP C-14

CORRECT-MRD II: Second Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease

Continue Reading »
EA2201

Testing Nivolumab and Ipilimumab With Short-Course Radiation in Advanced Rectal Cancer

Continue Reading »
MK-7339-003

Efficacy and Safety of Olaparib, Olaparib + Bevacizumab Compared to Bevacizumab + 5-Fluorouracil (FU)

Continue Reading »
NRG-GI005

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Continue Reading »
S1820

Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors

Continue Reading »
WF-1806

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

Continue Reading »
A021502

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

Continue Reading »

Search Again